MCID: LYM002
MIFTS: 36

Lymphoplasmacyte-Rich Meningioma

Categories: Cancer diseases, Immune diseases, Neuronal diseases

Aliases & Classifications for Lymphoplasmacyte-Rich Meningioma

MalaCards integrated aliases for Lymphoplasmacyte-Rich Meningioma:

Name: Lymphoplasmacyte-Rich Meningioma 12 15 17 71
Lymphoplasmocyte-Rich Meningioma 12
Meningioma 71

Classifications:



External Ids:

Disease Ontology 12 DOID:4591
NCIt 49 C4720
SNOMED-CT 67 19453003
UMLS 71 C0025286 C0431119

Summaries for Lymphoplasmacyte-Rich Meningioma

MalaCards based summary : Lymphoplasmacyte-Rich Meningioma, also known as lymphoplasmocyte-rich meningioma, is related to meningioma, radiation-induced and meningioma, familial. An important gene associated with Lymphoplasmacyte-Rich Meningioma is MIB1 (Mindbomb E3 Ubiquitin Protein Ligase 1), and among its related pathways/superpathways are Cell adhesion molecules (CAMs) and Hematopoietic Stem Cell Differentiation Pathways and Lineage-specific Markers. The drugs Thrombin and Fibrin Tissue Adhesive have been mentioned in the context of this disorder. Affiliated tissues include brain, bone and pituitary.

Related Diseases for Lymphoplasmacyte-Rich Meningioma

Diseases related to Lymphoplasmacyte-Rich Meningioma via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 41)
# Related Disease Score Top Affiliating Genes
1 meningioma, radiation-induced 10.9
2 meningioma, familial 10.9
3 spinal meningioma 10.9
4 secretory meningioma 10.9
5 rapidly involuting congenital hemangioma 10.9
6 rosai-dorfman disease 10.4
7 igg4-related disease 10.4
8 brain edema 10.4
9 idiopathic hypertrophic pachymeningitis 10.4
10 igg4-related pachymeningitis 10.4
11 hydrops, lactic acidosis, and sideroblastic anemia 10.3
12 headache 10.3
13 ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus 10.1
14 brain meningioma 10.1
15 fibrous dysplasia 10.1
16 optic nerve disease 10.1
17 hyperostosis 10.1
18 histiocytosis 10.1
19 jugular foramen meningioma 10.1
20 angiomatous meningioma 10.1
21 47,xyy 10.1
22 dysphagia 10.1
23 posttransplant acute limbic encephalitis 10.1
24 rare surgical neurologic disease 10.1
25 histiocytic sarcoma 9.9 CD68 CD163
26 reticulohistiocytic granuloma 9.9 CD68 CD163
27 necrobiosis lipoidica 9.8 CD68 CD163
28 balloon cell malignant melanoma 9.8 CD68 CD163
29 granuloma annulare 9.8 CD68 CD163
30 histiocytic and dendritic cell cancer 9.8 CD68 CD163
31 non-langerhans-cell histiocytosis 9.8 CD68 CD163
32 granulomatous dermatitis 9.8 CD68 CD163
33 adult xanthogranuloma 9.8 CD68 CD163
34 dermis tumor 9.7 CD68 CD163
35 lymphoproliferative syndrome 1 9.7 CD68 CD163
36 glomeruloid hemangioma 9.7 SDC1 CD68
37 fibrous histiocytoma 9.7 CD68 CD163
38 histiocytoma 9.6 CD68 CD163
39 langerhans cell histiocytosis 9.5 CD68 CD163
40 tenosynovial giant cell tumor 9.5 PGM1 CD68 CD163
41 synovitis 9.4 CD68 CD163

Graphical network of the top 20 diseases related to Lymphoplasmacyte-Rich Meningioma:



Diseases related to Lymphoplasmacyte-Rich Meningioma

Symptoms & Phenotypes for Lymphoplasmacyte-Rich Meningioma

Drugs & Therapeutics for Lymphoplasmacyte-Rich Meningioma

Drugs for Lymphoplasmacyte-Rich Meningioma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 251)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Thrombin Approved, Investigational Phase 4
2 Fibrin Tissue Adhesive Phase 4
3 Hemostatics Phase 4
4 Coagulants Phase 4
5
Tranexamic Acid Approved Phase 3 1197-18-8 5526
6
Progesterone Approved, Vet_approved Phase 3 57-83-0 5994
7
Donepezil Approved Phase 3 120014-06-4 3152
8
Cisplatin Approved Phase 3 15663-27-1 84093 441203 2767
9
Ondansetron Approved Phase 3 99614-02-5 4595
10
Granisetron Approved, Investigational Phase 3 109889-09-0 3510
11
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 3 437-38-7 3345
12
Cisatracurium Approved Phase 3 96946-41-7
13
Sevoflurane Approved, Vet_approved Phase 3 28523-86-6 5206
14
Propofol Approved, Investigational, Vet_approved Phase 3 2078-54-8 4943
15
Magnesium Sulfate Approved, Investigational, Vet_approved Phase 3 7487-88-9 24083
16
Dopamine Approved Phase 3 51-61-6, 62-31-7 681
17
Methylphenidate Approved, Investigational Phase 3 113-45-1 4158
18
Histamine Approved, Investigational Phase 3 51-45-6 774
19
Cyproheptadine Approved Phase 3 129-03-3 2913
20
Calcium Approved, Nutraceutical Phase 3 7440-70-2 271
21 Pancreatic Polypeptide Investigational Phase 3 59763-91-6
22 Antifibrinolytic Agents Phase 3
23 Progestins Phase 3
24 Nootropic Agents Phase 3
25 Cholinergic Agents Phase 3
26 Cholinesterase Inhibitors Phase 3
27 Liver Extracts Phase 3
28 Cola Phase 3
29 Emetics Phase 3
30 Narcotics Phase 3
31 Anesthetics, General Phase 3
32 Analgesics, Opioid Phase 3
33 Adjuvants, Anesthesia Phase 3
34 Anesthetics, Intravenous Phase 3
35 Antihypertensive Agents Phase 3
36 Analgesics Phase 3
37 Tocolytic Agents Phase 3
38 Anti-Arrhythmia Agents Phase 3
39 Vasoconstrictor Agents Phase 3
40 Anesthetics Phase 3
41 Anticonvulsants Phase 3
42 Central Nervous System Depressants Phase 3
43 Calcium, Dietary Phase 3
44 calcium channel blockers Phase 3
45 Gastrointestinal Agents Phase 3
46 Central Nervous System Stimulants Phase 3
47 Neurotransmitter Agents Phase 3
48 Dermatologic Agents Phase 3
49 Dopamine Uptake Inhibitors Phase 3
50 Dexmethylphenidate Hydrochloride Phase 3

Interventional clinical trials:

(show top 50) (show all 202)
# Name Status NCT ID Phase Drugs
1 Neurocognitive Outcome Assessment in Patients With Peri-optic Meningiomas After Excision With Or Without Pealing Of The Outer Layer Of The Cavernous Sinus: A Randomized Controlled Single Blinded Trial. Unknown status NCT03190122 Phase 4
2 Dissection of the Outer Layer of the Lateral Wall of the Cavernous Sinus Decreases Bleeding as Compared to Direct Tumor Attack in Middle Fossa Meningiomas: A Randomized Controlled Trial Unknown status NCT02863484 Phase 4
3 A Prospective, Randomized, Controlled Phase IV Study to Compare Bioseal Versus Standard of Care as an Adjunct to Hemostasis in Elective Brain Tumor Surgery Completed NCT02034799 Phase 4
4 PHASE 3 STUDY OF EFFICACY OF TRANEXAMIC ACID IN BRAIN TUMORS RESECTIONS Unknown status NCT01655927 Phase 3 Tranexamic Acid;Placebo: Saline
5 Efficacy of Stereotactic Conformal Radiotherapy (SCRT) Compared to Conventional Radiotherapy in Minimising Late Sequelae in Children and Young Adults With Brain Tumours: a Randomised Clinical Trial Unknown status NCT00517959 Phase 3
6 Double Blind Randomized Trial of the Anti-Progestational Agent Mifepristone In The Treatment of Unresectable Meningioma Completed NCT03015701 Phase 3 Mifepristone
7 Phase III Double Blind, Placebo Controlled Study of Donepezil in the Irradiated Brain Completed NCT00369785 Phase 3 donepezil hydrochloride;Placebo
8 Prospective Study Of Patients With Recurrent Or Incomplete Excised Benign Intercranial Meningiomas For The Evaluation Of Treatment Result With Combined Proton And Photon Irradiation To Doses 55.8 Or 63.0 CGE Completed NCT02947984 Phase 3
9 Randomized Controlled Trial of Acupressure to Control Chemotherapy-Induced Nausea (CIN) in Children Receiving Highly Emetogenic Chemotherapy Completed NCT01346267 Phase 3
10 A Randomized, Double-blind, Placebo-controlled Multi-center Study to Evaluate the Safety and Efficacy of Fentanyl Sublingual Spray (Fentanyl SL Spray) for the Treatment of Breakthrough Cancer Pain Completed NCT00538850 Phase 3 Fentanyl sublingual spray;Placebo
11 Phase III Trial of Observation Versus Irradiation for a Gross Totally Resected Grade II Meningioma Recruiting NCT03180268 Phase 3
12 The Effect of Magnesium Sulphate on Intraoperative Blood Loss in Meningioma Patient Undergoing Craniotomy With Tumor Removal Not yet recruiting NCT03558516 Phase 3 Magnesium group;Normal saline group
13 Observation Versus Conventional-Fractionated Radiotherapy or Radiosurgery After Non-radical Surgery for Benign Intracranial Meningiomas: A Phase III Study Terminated NCT00104936 Phase 3
14 A Phase III, Double-Blind, Prospective Randomized Clinical Trial of the Effect of D-threo-methylphenidate HCl (d-MPH) on Quality of Life in Brain Tumor Patients Receiving Radiation Therapy Terminated NCT00031798 Phase 3 methylphenidate hydrochloride
15 Prevention of Cancer/Treatment-Related Weight Loss in Children at High Nutritional Risk Terminated NCT01132547 Phase 3 cyproheptadine hydrochloride
16 Phase II Study of Hydroxyurea for the Treatment of Recurrent and/or Nonoperable Meningioma Unknown status NCT00006119 Phase 2 hydroxyurea
17 Phase II Trial of Observation for Low-Risk Meningiomas and of Radiotherapy for Intermediate- and High-Risk Meningiomas Unknown status NCT00895622 Phase 2
18 IMATINIB Plus Hydroxyurea in the Treatment of Recurrent or Progressive Meningiomas: a Randomized Phase II Study Unknown status NCT00904735 Phase 2 hydroxyurea;imatinib mesylate
19 Combination of Everolimus and Octreotide LAR in Aggressive Recurrent Meningiomas. Unknown status NCT02333565 Phase 2 Everolimus;Octreotide
20 Feasibility and Phase II Study Using Proton Radiation For WHO Grade I-III Meningiomas and Hemangiopericytomas Unknown status NCT01117844 Phase 1, Phase 2
21 Proton Radiation for Low Grade Gliomas Unknown status NCT01024907 Phase 1, Phase 2
22 Trabectedin for Recurrent Grade II or III Meningioma: a Randomized Phase II Study of the EORTC Brain Tumor Group Completed NCT02234050 Phase 2 Trabectedin
23 Phase II Study of Hydroxyurea for Unresectable Meningioma Completed NCT00003590 Phase 2 hydroxyurea
24 A Phase II Trial of PTK-787 in Recurrent or Progressive Meningiomas Completed NCT00348790 Phase 2 vatalanib
25 Phase II Study of Monthly SOM230C for Recurrent or Progressive Meningioma Completed NCT00859040 Phase 2 SOM230C
26 Adjuvant Postoperative High-Dose Radiotherapy for Atypical and Malignant Meningioma: a Phase-II and Observation Study Completed NCT00626730 Phase 2
27 ZD1839 FOR Treatment Of Recurrent Or Progressive Malignant Astrocytoma Or Glioblastoma And Recurrent Or Progressive Meningioma: A Phase II Study With A Phase I Component For Patients Receiving EIAEDs Completed NCT00025675 Phase 2 gefitinib
28 A Phase II Study of Imatinib Mesylate Plus Hydroxyurea in the Treatment of Patients With Recurrent/Progressive Meningioma Completed NCT00354913 Phase 2 hydroxyurea;imatinib mesylate
29 Phase II Trial of STI571 (NSC 716051) in Patients With Recurrent Meningioma Completed NCT00045734 Phase 2 imatinib mesylate
30 Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma Completed NCT00589784 Phase 2 Sunitinib
31 A Feasibility Study of Armodafinil for Brain Radiation-Induced Fatigue Completed NCT01032200 Phase 2 Armodafinil
32 Phase I/II Trial of STI571 (NSC 716051) in Patients With Recurrent Malignant Gliomas Completed NCT00010049 Phase 1, Phase 2 imatinib mesylate
33 Levetiracetam and Pregabalin for Monotherapy in Patients With Brain Tumors and Seizures. A Phase II Randomized Study. Completed NCT00629889 Phase 2 levetiracetam;pregabalin
34 A Phase I/II Trial of OSI-774 in Patients With Recurrent Malignant Gliomas and Malignant Gliomas Post Radiation Therapy Completed NCT00045110 Phase 1, Phase 2 erlotinib hydrochloride
35 A Randomized Phase II Trial of Bevacizumab to Control Brain Radiation Damage Completed NCT00492089 Phase 2 bevacizumab;placebo
36 A Phase II Trial of Rebeccamycin Analogue (NSC #655649) in Children With Solid Tumors Completed NCT00006102 Phase 2 becatecarin
37 Phase II Treatment of Children With Newly Diagnosed Malignant Central Nervous System Tumors With Temozolomide Prior to Radiation Therapy Completed NCT00005955 Phase 2 temozolomide
38 Donepezil and EGb761 in Improving Neurocognitive Function in Patients Who Have Previously Undergone Radiation Therapy for Primary Brain Tumor or Brain Metastases Completed NCT00070161 Phase 2 donepezil hydrochloride
39 A Phase I/II Trial of SU5416 in Patients With Recurrent High Grade Astrocytomas or Mixed Gliomas Completed NCT00004868 Phase 1, Phase 2 semaxanib
40 Phase I Study of At-Labeled Anti-Tenascin Human/Mouse Chimeric Monoclonal Antibody 81C6 (ch81C6) Via Surgically Created Cystic Resection Cavity in the Treatment of Patients With Primary or Metastatic Brain Tumors Completed NCT00003461 Phase 1, Phase 2
41 Phase II Trial of Irinotecan in Children With Refractory Solid Tumors Completed NCT00004078 Phase 2 irinotecan hydrochloride
42 Phase II Study to Evaluate the Efficacy of Recombinant Interferon-Alpha in the Treatment of Recurrent Unresectable Meningiomas and Malignant Meningiomas Completed NCT00002965 Phase 2
43 Phase II Trial Of High Dose Cyclophosphamide, Cisplatin And Carmustine With Stem Cell Reconstitution Followed By Specific Cellular Therapy In Patients With Recurrent Or Refractory Brain Tumors Completed NCT00014573 Phase 2 carmustine;cisplatin;cyclophosphamide;paclitaxel
44 Combination of Hydroxyurea and Verapamil for Refractory Meningiomas Completed NCT00706810 Phase 2 Hydroxyurea;Verapamil
45 Phase II Trial of Pembrolizumab in Recurrent or Residual High Grade Meningioma Recruiting NCT03279692 Phase 2 Pembrolizumab
46 A Single Arm, Open-label, Multicenter Phase II Study of 177Lu-DOTATATE Radionuclide in Adults With Progressive or High-risk Meningioma Recruiting NCT03971461 Phase 2 Lutathera
47 An Open-Label Phase II Study of Nivolumab in Adult Participants With Recurrent High-Grade Meningioma Recruiting NCT02648997 Phase 2 Nivolumab - 240 mg;Ipilimumab - 3 mg/kg;Nivolumab - 480 mg;Nivolumab - 1 mg/kg
48 A Phase II, Open-label, Single Arm Trial of Pembrolizumab for Refractory Atypical and Anaplastic Meningioma Recruiting NCT03016091 Phase 2 Pembrolizumab
49 A Single Arm Phase II Study Of The Dual mTORC1/mTORC2 Inhibitor Vistusertib (AZD2014) Provided On An Intermittent Schedule For Sporadic Patients With Grade II-III Meningiomas That Recur Or Progress After Surgery And Radiation Recruiting NCT03071874 Phase 2 AZD2014
50 Effect of Hippocampal Sparing on Neurocognitive Functions and Quality of Live in Patients Irradiated in the Neurocranial Area Recruiting NCT01849484 Phase 2

Search NIH Clinical Center for Lymphoplasmacyte-Rich Meningioma

Genetic Tests for Lymphoplasmacyte-Rich Meningioma

Anatomical Context for Lymphoplasmacyte-Rich Meningioma

MalaCards organs/tissues related to Lymphoplasmacyte-Rich Meningioma:

40
Brain, Bone, Pituitary, Spinal Cord, Breast, Lung, Pineal

Publications for Lymphoplasmacyte-Rich Meningioma

Articles related to Lymphoplasmacyte-Rich Meningioma:

(show top 50) (show all 14013)
# Title Authors PMID Year
1
Mania and psychosis associated with right parietal meningioma. 61
31698993 2020
2
Utility of dual-energy CT for predicting the vascularity of meningiomas. 61
31864141 2020
3
Meningioma can lead to pre-operative cognitive alterations even if localized in sensorimotor areas: A multimodal MRI-neuropsychological study in a series of 46 patients. 61
31790726 2020
4
MN1, FOXP1 and hsa-miR-181a-5p as prognostic markers in acute myeloid leukemia patients treated with intensive induction chemotherapy and autologous stem cell transplantation. 61
31927137 2020
5
Clinicoradiologic Characteristics of Temporal Bone Meningioma: Multicenter Retrospective Analysis. 61
32011010 2020
6
How long is the tail end of the learning curve? Results from 1000 consecutive endoscopic endonasal skull base cases following the initial 200 cases. 61
32032942 2020
7
Differentiating intracranial solitary fibrous tumor/hemangiopericytoma from meningioma using diffusion-weighted imaging and susceptibility-weighted imaging. 61
31673748 2020
8
Metastatic meningioma: Case report of a WHO grade I meningioma with liver metastases and review of the literature. 61
31762868 2020
9
Corrigendum to "Gamma Knife stereotactic radiosurgery for cerebellopontine angle meningioma" [Clin. Neurol. Neurosurg. 187 (2019) 105557]. 61
31928856 2020
10
Spectrochemical differentiation of meningioma tumours based on attenuated total reflection Fourier-transform infrared (ATR-FTIR) spectroscopy. 61
31865413 2020
11
Everolimus and Octreotide for Patients with Recurrent Meningioma: Results from the Phase II CEVOREM Trial. 61
31969329 2020
12
Meningioma in mature cystic teratoma of the ovary: clinical and computed tomography findings. 61
32024553 2020
13
SNHG1/miR-556-5p/TCF12 feedback loop enhances the tumorigenesis of meningioma through Wnt signaling pathway. 61
31692066 2020
14
[Intra-cranial meningiomas - Management of the patients in the microsurgery era]. 61
32022496 2020
15
Predictors of preoperative endovascular embolization of meningiomas: subanalysis of anatomic location and arterial supply. 61
31308198 2020
16
Pterional Craniotomy for Resection of Clinoidal Meningioma Associated With an Aerated Anterior Clinoid Process: 2-Dimensional Operative Video. 61
31120131 2020
17
Letter: Treatment of Asymptomatic Meningioma With Gamma Knife Radiosurgery: Long-Term Follow-up With Volumetric Assessment and Clinical Outcome. 61
32023346 2020
18
In Reply: Treatment of Asymptomatic Meningioma With Gamma Knife Radiosurgery: Long-Term Follow-up With Volumetric Assessment and Clinical Outcome. 61
32023347 2020
19
Letter regarding "Cognitive outcomes in meningioma patients undergoing surgery: individual changes over time and predictors of late cognitive functioning". 61
32027373 2020
20
Sellar surprises: a single-centre experience of unusual sellar masses. 61
31910151 2020
21
Indications and outcome in surgically treated asymptomatic meningiomas: a single-center case-control study. 61
32016587 2020
22
Treatment of traumatic intracranial aneurysm: Experiences at a single center. 61
31812032 2020
23
The challenge of overcoming the language barrier for brain tumor awake surgery in migrants: a feasibility study in five patient cases. 61
31650333 2020
24
Impact of postoperative radiotherapy on recurrence of primary intracranial atypical meningiomas. 61
31900826 2020
25
A novel framework for spatial normalization of dose distributions in voxel-based analyses of brain irradiation outcomes. 61
31918368 2020
26
Evaluation of Epidemiologic Factors, Radiographic Features, and Pathologic Findings for Predicting Peritumoral Brain Edema in Meningiomas. 61
31922353 2020
27
Phosphoproteomic and Kinomic Signature of Clinically Aggressive Grade I (1.5) Meningiomas Reveals RB1 Signaling as a Novel Mediator and Biomarker. 61
31615938 2020
28
In reply to the letter to the editor regarding 'Cognitive outcomes in meningioma patients undergoing surgery: Individual changes over time and predictors of late cognitive functioning'. 61
32002557 2020
29
Molecular characteristics of meningiomas. 61
31964111 2020
30
Inflammatory Myofibroblastic Tumor of Spinal Canal: Brief Case Report. 61
31962352 2020
31
Metabolomic Profile of Aggressive Meningiomas by Using High-Resolution Magic Angle Spinning Nuclear Magnetic Resonance. 61
31679342 2020
32
Brachytherapy with surgical resection as salvage treatment for recurrent high-grade meningiomas: a matched cohort study. 61
31745706 2020
33
A retrospective survey on canine intracranial tumors between 2007 and 2017. 61
31801930 2020
34
Gamma Knife Radiosurgery for Anterior Clinoid Process Meningiomas: A Series of 61 Consecutive Patients. 61
31562964 2020
35
Evolving Strategies for Resection of Sellar/Parasellar Synchronous Tumors via Endoscopic Endonasal Approach: A Technical Case Report and Systematic Review of the Literature. 61
31476461 2020
36
Treatment of complex intracranial pathologies with transcirculation endovascular approaches. 61
31987753 2020
37
A recurrent case of pituicytoma 16 years later. 61
31964155 2020
38
Shunt-Bronchial Fistula with Coughing Up and Swallowing of Cerebrospinal Fluid: Rare Complication of Ventriculopleural Shunt. 61
31872190 2020
39
Craniocervical Rosai-Dorfman Disease Involving the Vertebral Artery: Case Report and Literature Review. 61
31550540 2020
40
Artery of Davidoff and Schechter Supply in Dural Arteriovenous Fistulas. 61
31974076 2020
41
Remote Pontine Hemorrhage After Left Frontal Lobe Meningioma Resection Presenting as Bilateral Internuclear Ophthalmoplegia. 61
31972712 2020
42
Differentiating microcystic meningioma from atypical meningioma using diffusion-weighted imaging. 61
31996968 2020
43
YAP1-fusions in pediatric NF2-wildtype meningioma. 61
31734728 2020
44
Seeding of infection in previously asymptomatic meningioma. 61
31959614 2020
45
How to differentiate spinal cord hemangiopericytoma from common spinal cord tumor? 61
31953073 2020
46
Multisession radiosurgery for intracranial meningioma treatment: study protocol of a single arm, monocenter, prospective trial. 61
32000819 2020
47
A Report of Intracranial Meningioma Recurring as Ectopic Orbital Meningioma Associated With Basal Encephalocele. 61
31895728 2020
48
Transcranial color-coded sonography may indirectly reveal an intracranial meningioma. 61
31120556 2020
49
Successful resolution of the ophthalmic manifestations of a falcotentorial meningioma through Cerebrospinal fluid diversion. 61
31843434 2020
50
Individual-patient prediction of meningioma malignancy and survival using the Surveillance, Epidemiology, and End Results database. 61
32025573 2020

Variations for Lymphoplasmacyte-Rich Meningioma

Expression for Lymphoplasmacyte-Rich Meningioma

Search GEO for disease gene expression data for Lymphoplasmacyte-Rich Meningioma.

Pathways for Lymphoplasmacyte-Rich Meningioma

Pathways related to Lymphoplasmacyte-Rich Meningioma according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 11.32 SDC1 CLDN6
2 10.86 SDC1 CD68 CD163
3 10.81 CD68 CD163

GO Terms for Lymphoplasmacyte-Rich Meningioma

Sources for Lymphoplasmacyte-Rich Meningioma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....